![Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis - Biology of Blood and Marrow Transplantation Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/4d982194-d95a-4575-af5a-20f54abbbfa0/ybbmt54956-fig-0001_lrg.jpg)
Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis - Biology of Blood and Marrow Transplantation
![Overall survival of patients with stage I follicular lymphoma in the... | Download Scientific Diagram Overall survival of patients with stage I follicular lymphoma in the... | Download Scientific Diagram](https://www.researchgate.net/publication/230723995/figure/fig2/AS:406903982182406@1474024877754/Overall-survival-of-patients-with-stage-I-follicular-lymphoma-in-the-National-LymphoCare.png)
Overall survival of patients with stage I follicular lymphoma in the... | Download Scientific Diagram
![PDF] Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS). | Semantic Scholar PDF] Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/acfb0c49e62bc861029ae15f97530c20aacd4c8b/24-Table1-1.png)
PDF] Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS). | Semantic Scholar
![Diagnostics | Free Full-Text | Pretreatment CT Texture Parameters as Predictive Biomarkers of Progression-Free Survival in Follicular Lymphoma Treated with Immunochemotherapy and Rituximab Maintenance Diagnostics | Free Full-Text | Pretreatment CT Texture Parameters as Predictive Biomarkers of Progression-Free Survival in Follicular Lymphoma Treated with Immunochemotherapy and Rituximab Maintenance](https://www.mdpi.com/diagnostics/diagnostics-13-02237/article_deploy/html/images/diagnostics-13-02237-g001.png)
Diagnostics | Free Full-Text | Pretreatment CT Texture Parameters as Predictive Biomarkers of Progression-Free Survival in Follicular Lymphoma Treated with Immunochemotherapy and Rituximab Maintenance
![Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial | Bone Marrow Transplantation Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41409-020-01182-w/MediaObjects/41409_2020_1182_Fig1_HTML.png)
Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial | Bone Marrow Transplantation
![Stage-specific trends in primary therapy and survival in follicular lymphoma: a nationwide population-based analysis in the Netherlands, 1989–2016 | Leukemia Stage-specific trends in primary therapy and survival in follicular lymphoma: a nationwide population-based analysis in the Netherlands, 1989–2016 | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-020-01048-6/MediaObjects/41375_2020_1048_Fig1_HTML.png)
Stage-specific trends in primary therapy and survival in follicular lymphoma: a nationwide population-based analysis in the Netherlands, 1989–2016 | Leukemia
![Analysis of the National LymphoCare Study Evaluating Early Disease Progression in Patients with FL within 2 Years of R-CHOP | Research To Practice Analysis of the National LymphoCare Study Evaluating Early Disease Progression in Patients with FL within 2 Years of R-CHOP | Research To Practice](http://www.researchtopractice.com/sites/default/files/imagecache/slideshow_image/5mjc/slides/2011/5MJCASH2014/3/1/Slide02.jpg)
Analysis of the National LymphoCare Study Evaluating Early Disease Progression in Patients with FL within 2 Years of R-CHOP | Research To Practice
![Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies | Oncology and Therapy Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies | Oncology and Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40487-021-00161-5/MediaObjects/40487_2021_161_Fig1_HTML.png)
Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies | Oncology and Therapy
![The outcome of watchful waiting in patients with previously treated follicular lymphoma - Fujino - 2022 - Cancer Medicine - Wiley Online Library The outcome of watchful waiting in patients with previously treated follicular lymphoma - Fujino - 2022 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0238a5c3-b5d1-4570-8a52-08aeee98ee27/cam44588-fig-0002-m.jpg)
The outcome of watchful waiting in patients with previously treated follicular lymphoma - Fujino - 2022 - Cancer Medicine - Wiley Online Library
![Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non‐interventional study MabSCale - Dürig - 2023 - Cancer Medicine - Wiley Online Library Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non‐interventional study MabSCale - Dürig - 2023 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ec0a755d-86c6-4e22-8b7d-a7e0c5e0a3f0/cam45160-toc-0001-m.jpg?trick=1688992257010)
Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non‐interventional study MabSCale - Dürig - 2023 - Cancer Medicine - Wiley Online Library
![Analysis of the National LymphoCare Study Evaluating Early Disease Progression in Patients with FL within 2 Years of R-CHOP | Research To Practice Analysis of the National LymphoCare Study Evaluating Early Disease Progression in Patients with FL within 2 Years of R-CHOP | Research To Practice](http://www.researchtopractice.com/sites/default/files/imagecache/slideshow_image/5mjc/slides/2011/5MJCASH2014/3/1/Slide01.jpg)
Analysis of the National LymphoCare Study Evaluating Early Disease Progression in Patients with FL within 2 Years of R-CHOP | Research To Practice
![Analysis of the National LymphoCare Study Evaluating Early Disease Progression in Patients with FL within 2 Years of R-CHOP | Research To Practice Analysis of the National LymphoCare Study Evaluating Early Disease Progression in Patients with FL within 2 Years of R-CHOP | Research To Practice](http://www.researchtopractice.com/sites/default/files/imagecache/slideshow_image/5mjc/slides/2011/5MJCASH2014/3/1/Slide03.jpg)